Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 4, 2007, Pages 723-730

  Chang, Shih Chen ^a   Lacey Jr , James V ^a   Brinton, Louise A ^a   Hartge, Patricia ^a   Adams, Kenneth ^a   Mouw, Traci ^a   Carroll, Leslie ^b   Hollenbeck, Albert ^c   Schatzkin, Arthur ^a   Leitzmann, Michael F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c AARP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; WEIGHT GAIN;

AGED; BODY MASS INDEX; BODY WEIGHT; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 34247472628     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0675     Document Type: Article

References (35)

1. Vainio H, Bianchini F. Weight control and physical activity. Lyon (France): IARC Press; 2002.
2. Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 1973;36:207-14.
3. Key TJ, Pike MC. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57:205-12.
4. Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995;85:304-13.
5. Nelson HD. Postmenopausal estrogen for treatment of hot flashes: clinical applications. JAMA 2004;291:1621-5.
6. Whitehead MI, Fraser D. The effects of estrogens and progestogens on the endometrium. Modern approach to treatment. Obstet Gynecol Clin North Am 1987;14:299-320.
7. Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst 2004;96:1635-8.
8. Xu WH, Matthews CE, Xiang YB, et al. Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women. Am J Epidemiol 2005;161:939-47.
9. Xu WH, Xiang YB, Zheng W, et al. Weight history and risk of endometrial cancer among Chinese women. Int J Epidemiol 2006;35:159-66.
10. Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA. Weight change and risk of endometrial cancer. Int J Epidemiol 2006;35:151-8.
11. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421-30.
12. Terry P, Baron JA, Weiderpass E, Yuen J, Lichtenstein P, Nyren O. Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer 1999;82:38-42.
13. Blitzer PH, Blitzer EC, Rimm AA. Association between teen-age obesity and cancer in 56,111 women: all cancers and endometrial carcinoma. Prev Med 1976;5:20-31.
14. La Vecchia C, Franceschi S, Gallus G, et al. Oestrogens and obesity as risk factors for endometrial cancer in Italy. Int J Epidemiol 1982;11:120-6.
15. Schatzkin A, Subar AF, Thompson FE, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001;154:1119-25.
16. Ellison JH, Wu XC, Howe HL, et al. Cancer in North America, 1998-2002. Volume three. NAACCR Combined Incidence Rates. Springfield (IL): North American Association of Central Cancer Registries, Inc.; 2005.
17. Michaud DS, Midthune D, Hermansen S, et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. Journal of Registry Management 2005;32:70-5.
18. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
19. Olson SH, Trevisan M, Marshall JR, et al. Body mass index, weight gain, and risk of endometrial cancer. Nutr Cancer 1995;23:141-9.
20. Swanson CA, Jones DY, Schatzkin A, Brinton LA, Ziegler RG. Breast cancer risk assessed by anthropometry in the NHANES I epidemiological follow-up study. Cancer Res 1988;485363-7.
21. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000;11:185-92.
22. Le Marchand L, Wilkens LR, Mi MP. Early-age body size, adult weight gain and endometrial cancer risk. Int J Cancer 1991;48:807-11.
23. Wynder EL, Escher GC, Mantel N. An epidemiological investigation of cancer of the endometrium. Cancer 1966;19:489-520.
24. Swanson CA, Potischman N, Wilbanks GD, et al. Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol Biomarkers Prev 1993;2:321-7.
25. Levi F, La Vecchia C, Negri E, Parazzini F, Franceschi S. Body mass at different ages and subsequent endometrial cancer risk. Int J Cancer 1992;50:567-71.
26. Henderson BE, Casagrande JT, Pike MC, Mack T, Rosario I, Duke A. The epidemiology of endometrial cancer in young women. Br J Cancer 1983;47:749-56.
27. Shu XO, Brinton LA, Zheng W, et al. Relation of obesity and body fat distribution to endometrial cancer in Shanghai, China. Cancer Res 1992;52:3865-70.
28. Brinton LA, Hoover RN; The Endometrial Cancer Collaborative Group. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. Obstet Gynecol 1993;81:265-71.
29. Newcomb PA, Trentham-Dietz A. Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States). Cancer Causes Control 2003;14:195-201.
30. Lacey JV, Jr., Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005;14:1724-31.
31. Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005;365:1543-51.
32. Zeleniuch-Jacquotte A, Akhmedkhanov A, Kato I, et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer 2001;84:975-81.
33. Potischman N, Gail MH, Troisi R, Wacholder S, Hoover RN. Measurement error does not explain the persistence of a body mass index association with endometrial cancer after adjustment for endogenous hormones. Epidemiology 1999;10:76-9.
34. Stevens J, Keil JE, Waid LR, Gazes PC. Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol 1990;132:1156-63.
35. Banks E, Beral V, Cameron R, et al. Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat 2001;6:357-63.